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access article under the CC BY-NC-NDSummary Background: Hand flexor tendon injuries are compromised with tendon adhesion.
Tendon adhesion forms between flexor tendon and tendon sheath, reduces the range of mo-
tion of fingers, and affects their function. Oxidative stress is increased in flexor tendon after
injury and might play a role in tendon adhesion formation. Trolox (6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid), a water-soluble analog of vitamin E, is antioxida-
tive. Trolox reduced oxidative stress and the expression of fibrotic cytokines in the bile
gut ligation animal model. Vitamin C and Trolox are strong antioxidants, but they might also
have prooxidant properties. The prooxidant properties of vitamin C and Trolox are different.
In this study, our aim was to determine the effect of Trolox in reducing tendon adhesion for-
mation.
Methods: Flexor digitorum profundus tendon injury was induced in 54 Kai-Mei Chicken ac-
cording to a well-established protocol. After wound closure, an injection of 50 mL saline,
10mM Trolox, or 100mM Trolox was administered into the wound area. At 2 weeks or 6 weeks
after the surgery, chicken feet were harvested for gliding test, high-resolution ultrasound
measurement on a fibrotic area, and histology.
Results: At Week 2 after the surgery, Trolox has no effect on the flexion angle and gliding
resistance, whereas a significant improvement was observed in the flexion angle and gliding
resistance in the Trolox-treated groups at Week 6. However, no dose response was observed.
In the ultrasound measurement, there was no significant difference in the fibrotic mass inof Orthopaedics and Traumatology, Chinese University of Hong Kong, 5/F Clinical Sciences Building,
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j.jot.2016.10.002the Trolox-treated group as compared to the saline group at Week 2. At Week 6, fibrotic mass
was significantly reduced in both Trolox-treated groups. From the histological examination,
the Trolox-treated groups presented a higher cellularity at Week 2 as compared to the saline
group, and reduced fibrosis and adhesion at Week 6.
Conclusion: Our results suggest that local administration of Trolox can reduce tendon adhe-
sion, and a higher dose of Trolox did not have negative effects.
Clinical Significance: Trolox solution might be feasible to reduce tendon adhesion via intrao-
perative injection at the wound area during tendon repair.
ª 2016 The Authors. Published by Elsevier (Singapore) Pte Ltd on behalf of Chinese Speaking
Orthopaedic Society. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Flexor tendon adhesions are a common clinical problem
presenting considerable challenge to orthopaedic surgeons.
Repair of flexor tendon is complicated by the progression of
fibrosis and a high rate of postoperative complication [1].
About 30e40% of cases resulted in a loss of digital range of
motion and impaired hand function in the United States [2].
Tendon adhesion, found between flexor tendon and syno-
vial sheath, is a result of fibrosis and immobilisation. The
flexor tendon healing process involves both intrinsic and
extrinsic mechanisms. The intrinsic mechanism involves
tenocytes, whereas the extrinsic mechanism involves in-
flammatory cells and fibroblasts [3,4] that promote tendon
adhesion [5].
Different approaches have been taken to reduce tendon
adhesion. For example, (1) an application of physical bar-
riers, such as Interceed [6], expanded polytetrafluoro-
ethylene, polyvinyl alcohol hydrogel [7], to prevent
adhesion between the tendon and synovial sheath; (2)
modified surgical techniques, such as multistrand repair
and sheath repair [7]; (3) application of growth factors
including VEGF, NF-kB, and bFGF [7,8]; (4) using pharma-
cological adjuvants, such as anti-inflammatory drugs NSAIDs
(nonsteroidal anti-inflammatory drugs) and TGFb-1 (trans-
forming growth factor beta 1), that suppress the extrinsic
mechanism [8,9]. Previously, we found that local adminis-
tration of a low dose of vitamin C (5 mg/mL) can signifi-
cantly reduce tendon adhesion by reducing oxidative stress
and inflammation in a chicken model [10,11]. However, a
higher dose of vitamin C was ineffective, which suggests
that vitamin C may elicit a different effect at higher doses.
Vitamin C is a cofactor in hydroxyproline synthesis, which
promotes collagen production and hence a fibrogenic
response.
In contrast to vitamin C, Trolox (6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid), a water-soluble
analogue of vitamin E, could significantly reduce oxidative
stress and prevent the upregulation of fibrotic cytokines,
such as TGFb-1 and interleukin-10 [10]. It is possible that
Trolox could be a better antioxidant as compared to vitamin
C in reducing tendon adhesion. In the present study, we
tested the hypothesis that intraoperative injection of Tro-
lox following flexor digitorum profundus tendon injury will
decrease tendon adhesion.Lee YW, et al., Local administrat
profundus tendon injury, JournaMaterials and methods
Animal model and injection
The Animal Research Ethics Committee of the Chinese
University of Hong Kong approved all animal experiments
conducted in this study. A total of 54 3-month-old female
Kamei chickens [Hong Kong Poultry (Kamei Chicken)
Development Limited, Hong Kong] were used in this study;
a well-established flexor digitorum profundus tendon injury
animal model was used [11,12]. In brief, 1e1.5 mL of ke-
tamine/xylazine (1:1) was intravenously injected to anes-
thetise the chicken. A 10-mm medial incision was made at
the proximal interphalangeal joint area of the third toe to
approach the flexor digitorum profundus tendon. Flexor
sheath was exposed via a blunt dissection to mobilise the
skin. A2 pulley, which is an annular pulley equivalent to the
A2 pulley in the human finger, was located just distal to the
proximal interphalangeal joint area, on the side of the
flexor sheath. After flexing the toe, the flexor digitorum
profundus was withdrawn through the opening. The super-
ficial tendon and vinculum longus were left untouched. At
the medial aspect of the tendon, three partial cuts at 4-mm
intervals were made. Each cut was 50% of the diameter of
the tendon. To repair the cuts, a single strand stitch using
5e0 Ethilon nonabsorbable nylon suture (Johnson & John-
son, New Brunswick, NJ, USA) was used to pass through all
three cuts simultaneously, and returned to the sheath in
neutral position. The 5e0 Ethilon nonabsorbable nylon su-
ture was used to close the opening of the sheath and skin
wound. The injured foot was immobilised in neutral posi-
tion for 2 weeks with a fiberglass cast (3M, St. Paul, MN,
USA), whereas the contralateral side served as an uninjured
and free-moving control.
After animal surgery, chickens were randomly assigned
to three different groups to receive a local injection of
50 mL saline, 10mM Trolox solution, or 100mM Trolox solu-
tion after the tendon sheath closure with suture. Leakage
of solutions was not observed after the injection. To
determine the effective dose for reducing tendon adhe-
sion, two doses of Trolox were used. The chickens were
sacrificed at 2 weeks or 6 weeks after the surgery (nZ 9 in
each group at each time point) for ultrasonography eval-
uation, gliding test, and histological examination. Both the
injured and contralateral feet were harvested. Feet wereion of Trolox, a vitamin E analog, reduced tendon adhesion in a
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gliding test was performed (within 1 month after sample
harvest).Ultrasound imaging and video-assisted gliding test
The chicken feet were thawed to room temperature prior
to taking ultrasound images and performing the gliding
test. Ultrasound and video-assisted gliding test were per-
formed as previously described [13]. In brief, to expose the
flexor sheath over the A2 pulley, the skin and subcutaneous
adipose tissue over the second phalanx of the long toe
were removed. Coupling gel was applied on top for ultra-
sound imaging. A Vevo 770 high-resolution ultrasound im-
aging system (Visualsonic, Toronto, Ontario, Canada) with
an RMV 711 scan head (6-mm focal length and 30-mm axial
resolution) was used to capture three-dimensional (3-D)
ultrasound images for a total length of 12 mm with a step
size of 32 mm. The A2 pulley was identified from the ac-
quired images by the built-in software. The cross-sectional
area of the flexor digitorum superficialis and the flexor
digitorum profundus were measured at 4 mm proximal to
the A2 pulley by two independent sonographers according
to the methods described in our previous study [13]. 3-D
ultrasound images were used to examine the fibrotic
response, tendon adhesion, and peritendinous reactions
near the injured sites in all groups. The chicken feet were
then mounted onto a custom-made testing jig for the
gliding test using a mechanical testing machine (H25KM;
Tinius Olsen, Salfords, UK) as described previously [13]. In
brief, the toe joints of the long toe were labeled and the
flexor digitorum profundus tendon was clamped to the
clamp head of a 50-N load with the long toe fully extended
in a naturally relaxed position. Flexor digitorum profundus
tendon was preloaded with 0.1 N. Displacement of the
gliding test was 15 mm, and the speed was 30 mm/min.
The gliding test was videorecorded. By matching the video
clip, forceedisplacement curve, mechanical data, and
maximum flexion angle, the gliding resistance could be
calculated. The joint flexion angle was measured from the
forceedisplacement curve using ImagePro (Media Cyber-
netics, Bethesda, MN, USA). The extent of tendon adhesion
in the injured flexor digitorum profundus tendon was pre-
sented as a percentage of the maximum flexion angle and
the gliding resistance in the contralateral control. The
tendon was kept moist during the gliding test, and the
chicken feet underwent histological processing after the
gliding test.Figure 1 The maximum flexion angle of the proximal inter-
phalangeal joint and the gliding resistance were calculated to
evaluate the extent of restrictive tendon adhesion. Significant
differences were observed at Week 6 between Trolox-treated
groups and the saline group. No difference was observed at
Week 2 between all groups. TroloxZ 6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid.Histological analysis
After the gliding test, a joint segment from the third toe
(including the A2 pulley) was dissected and fixed in 10%
buffered formalin overnight. After fixation, samples were
decalcified in 9% formic acid for 2 weeks, and embedded in
paraffin. Samples were sectioned at 7 mm sagittal section
for hematoxylin and eosin staining. The severity of tendon
adhesion was evaluated by examining the cellularity and
fibrotic response of the healing tendon in the peritendinous
region.Please cite this article in press as: Lee YW, et al., Local administrat
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The maximum flexion angle and the gliding resistance are
shown in box plots. The nonparametric KruskaleWallis test
was used to perform multiple group comparisons, and p
values were reported. Two-group comparisons were per-
formed using the ManneWhitney U test with Bonferroni
correction when necessary (aZ 0.05/2Z 0.025). All data
analyses were done using the Statistical Package for the
Social Sciences (SPSS) 16.0 (IBM, Armonk, NY, USA). A p
value 0.050 was regarded as statistically significant.
Result
Gliding test
At 2 weeks after the surgery, no significant difference was
found in the maximum flexion angle (Figure 1) and gliding
resistance (Figure 2) at the proximal interphalangeal joint
between the Trolox groups and the saline group. At 6 weeks
after the surgery, significant improvements in the restora-
tion of the maximum flexion angle were found in the 10mM
(pZ 0.007) and 100mM (pZ 0.025) Trolox groups as
compared to the saline group. However, only 10mM Trolox
significantly reduced the gliding resistance (pZ 0.039),
whereas 100mM Trolox did not (pZ 0.078).
Ultrasound measurement fibrotic size around
injured tendon
The fibrotic size of the injured flexor tendon was measured
using 3-D ultrasound imaging as described previously [13].ion of Trolox, a vitamin E analog, reduced tendon adhesion in a
l of Orthopaedic Translation (2016), http://dx.doi.org/10.1016/
Figure 2 The gliding resistance was calculated to evaluate
the extent of restrictive tendon adhesion. A significant differ-
ence was observed between Trolox (10 mg)-treated group and
saline group at Week 6. Similar to the results of maximum
flexion angle, no differences were observed between all groups
at Week 2. TroloxZ 6-hydroxy-2,5,7,8-tetramethylchroman-2-
carboxylic acid.
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size at Week 2 after the surgery (Figure 3); however, both
the low and high doses of Trolox reduced fibrotic size at
Week 6 after the surgery (pZ 0.022 and 0.018, respec-
tively) (Figure 3).Figure 3 (A) The cross-sectional area of flexor tendons (flexor
injured site was measured with 3-D ultrasound imaging to evaluate
of the fibrotic area was observed in the Trolox (100 mg)-treated gro
at Week 2. FDPZ flexor digitorum profundus tendon; FDSZ flex
tetramethylchroman-2-carboxylic acid.
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At Week 2 after the surgery, swelling of tendinous tissues
was observed at the wound site in all three groups, with
more peritendinous adhesion on the vinculum side. How-
ever, the cellularity in the gap of the wound was higher in
the Trolox-treated groups. At 6 weeks after the surgery,
fibrosis and tendon adhesion were still evident between the
flexor digitorum superficialis and flexor digitorum pro-
fundus in the saline group. The fibrotic response was
reduced in both Trolox-treated groups, but the edematous
swelling was observed in the high dose Trolox group. Peri-
tendinous adhesion was further resolved in the Trolox-
treated groups at 6 weeks after the surgery, and the
cellularity in the gap of the wound was decreased as
compared to 2 weeks after the surgery (Figure 4).Discussion
Effects of Trolox on tendon adhesion
We found that Trolox significantly reduced tendon adhesion
formation, resulting in a better restoration of the range of
motion and gliding properties at 6 weeks after the surgery.
Although its effect on tendon adhesion was not evident at 2
weeks after the surgery, Trolox promoted cell recruitment
to the wound site as shown in histology, which may imply its
potential in promoting healing at the proliferation phase.
As Trolox can decrease the expression of inflammatory cy-
tokines [11], its inhibitory effect on the formation of
tendon adhesion may be mediated through reducing fibrosis
associated with inflammatory processes [12]. Moreover, its
antioxidative effect may also contribute to the suppression
of fibrogenesis related to oxidative stress [14]. As compareddigitorum superficialis and flexor digitorum profundus) at the
the magnitude of fibrosis. (B) Significant difference in reduction
up at Week 6, whereas there was no difference across all groups
or digitorum sperficialis tendon; TroloxZ 6-hydroxy-2,5,7,8-
ion of Trolox, a vitamin E analog, reduced tendon adhesion in a
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Figure 4 Histological examination of injured flexor digitorum profundus tendon at Week 2 and Week 6 after the surgery (H&E,
12.5 optical magnifications). Higher magnification (200) view of the wound is shown in the corner. Wound: the wound resulted
from 50% tenotomy. FDPZ flexor digitorum profundus tendon; FDSZ flexor digitorum sperficialis tendon; H&EZ hematoxylin and
eosin; TroloxZ 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid. Yellow arrow indicates the boundary of wound; white
asterisk indicates fibrosis and adhesion; red rectangle indicates the higher magnification area.
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the effect of Trolox to reduce tendon adhesion is less dose-
dependent. Because Trolox does not promote collagen
synthesis as vitamin C does, this may account for the dif-
ference in dose response. Moreover, the differences in
antioxidative effects between Trolox and vitamin C may
also contribute to the different outcomes in reducing
tendon adhesion. Trolox can suppress lipid peroxidation,
whereas vitamin C can become prooxidative in the pres-
ence of ferrous ions [15]. Therefore, our preliminary data
support the concept that Trolox is probably a better choice
for local administration of antioxidants in reducing tendon
adhesion.Limitation
Although we observed treatment effects of Trolox in
reducing tendon adhesion, the mechanism of the treatment
effect remains speculative. Further investigation on the
effects of Trolox on the recruitment of fibroblasts and
tenoblasts may help explain the present observations. As
compared to the saline group, large intragroup variations in
treatment effects have been observed in Trolox-treated
groups, which may imply some uncontrolled variables, such
as the location of and retention of injected Trolox. As the
intrasynovial space is large, a specific drug carrier may be
necessary to localise the drug in the wound site where
tendon adhesion is more likely to develop. As Trolox is
relatively safe and can be metabolised [16], its future
clinical use as a pharmacological adjuvants is envisaged.Conclusion
The local administration of Trolox can reduce tendon
adhesion.Please cite this article in press as: Lee YW, et al., Local administrat
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